Indications for treatment.
D000562:Amebiasis / Q000628:therapy*; D000818:Animals; D004748:Entamoeba histolytica / Q000472:pathogenicity; D004749:Entamoebiasis / Q000469:parasitology / Q000628:therapy*; D006801:Humans; D007816:Larva Migrans, Visceral / Q000628:therapy*; D010272:Parasitic Diseases / Q000628:therapy*; D014122:Toxoplasma / Q000472:pathogenicity; D014123:Toxoplasmosis / Q000469:parasitology / Q000628:therapy*